1. Sign our petition calling on Cochrane to withdraw their review of Exercise Therapy for CFS here.
    Dismiss Notice
  2. Guest, the 'News in Brief' for the week beginning 8th April 2024 is here.
    Dismiss Notice
  3. Welcome! To read the Core Purpose and Values of our forum, click here.
    Dismiss Notice

Vericiguat [drug for heart failure mentioned by Prof Schiebenbogen]

Discussion in 'Drug and supplement treatments' started by Hutan, Sep 27, 2022.

  1. Hutan

    Hutan Moderator Staff Member

    Messages:
    26,844
    Location:
    Aotearoa New Zealand
    Moved from the News from Germany thread.

    From the twitter thread above:

    About vericiguat, which does sound interesting:
     
    Last edited by a moderator: Oct 3, 2022
    sb4, SNT Gatchaman, janice and 9 others like this.
  2. FMMM1

    FMMM1 Senior Member (Voting Rights)

    Messages:
    2,628
    One for @Snow Leopard - from memory you are interested in the NO pathway, vasodilation.
     
  3. RedFox

    RedFox Senior Member (Voting Rights)

    Messages:
    1,245
    Location:
    Pennsylvania
    It's very fortunate that they've got funding to try some things. I think the idea of trialing medications that dilate blood vessels is rather odd, but I'm not up on the latest research on the cardiovascular system. If it's rigorous the data will speak for themselves.

    In that vein (hehe), is anything known about the design of these studies? These are the first trials in the program, so I'm guessing they'll be small, but will they at least be blinded?

    I really want to see research that creates answers, not more questions.
     
    bobbler, cfsandmore, janice and 3 others like this.
  4. FMMM1

    FMMM1 Senior Member (Voting Rights)

    Messages:
    2,628
    Yea trialling medicines is one way of understanding ME/CFS and potentially treating it. Sometimes there's an accidental finding (e.g. treating someone with ME/CFS with drugs for another disease) which suggests the drug might work --- not sure that applies in this case.

    Fluge and Mella (of rituximab trial) patented something relating to NO in ME/CFS - can't remember the details. So focus on NO isn't entirely new.
     
    bobbler, cfsandmore, janice and 2 others like this.
  5. Sizzle

    Sizzle New Member

    Messages:
    2
    Peter Trewhitt likes this.

Share This Page